Prolumo® Lung Support

Name: Prolumo® Lung Support
Brand: Prolumo
Price: 210.00 USD
Availability: InStock

$210.00

AVAILABLE IN BOTH
2 WEEK & 4 WEEK
THERAPY OPTIONS

TARGETED THERAPY

Availability: 13266 In Stock

Features & Benefits

Prolumo® is an all-natural lung support supplement for use in equine athletes. The active ingredient, Notoginseng, provides proven hemostatic properties. Prolumo® is intended to be administered for both the acute and chronic horse with impaired or inflamed lungs. While each individual case can vary, a 14-28 days loading dose is recommended—1/2 tube twice daily. But, as always, consult with your veterinarian prior to initiating therapy.

Formulated to

Enhance Coagulation
Initiate Platelet Release
Reduce Clotting time
Manufactured under strict quality standards

Features & Benefits

Designed to Reduce Bleeding Caused During Strenuous Exercise
Palatable Formulation

Dosing

Following the initial incident, administer ½ tube by mouth twice daily for 2-4 weeks, or as recommended by your veterinarian. A maintenance dosing regimen of ½ tube by mouth once daily is recommended thereafter.

Product Facts

How Supplied? : 1 tube = two 15 ml doses. One case = 14 tubes

Size : 1 tube = 30ml’s

Active Ingredients per 15ml dose - A proprietary blend of Honey, Notoginseng, radix rhizome extract containing Rg1, Rb1, and R1 saponins, and Pantothenic Acid (Vitamin B5) – 6960mg

Inactive Ingredients per 15ml dose – Apple Cider Vinegar, Corn Oil, Dextrose, Glycerin (coconut), Sodium Propionate, Water, & Xanthan Gum

Store in a cool, dry area

Cautions & Warnings

FOR ANIMAL USE ONLY. Safe use in pregnant animals or animals intended for breeding has not been proven. An examination from a veterinarian is recommended prior to using this product. Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately. This product should not be given to animals intended for human consumption.

Prolumo® Lung Support

AVAILABLE IN BOTH
2 WEEK & 4 WEEK
THERAPY OPTIONS

TARGETED THERAPY